Jump to content

Preventing And Treating Lung Cancer -- ESMO Explores

Recommended Posts

Collaboration To Fight Cancer On All Fronts

http://www.medicalnewstoday.com/medical ... wsid=66822

Main Category: Cancer / Oncology News

Article Date: 05 Apr 2007 - 15:00 PDT

Leading figures in the global fight against lung cancer met in the city of Geneva, Switzerland last week to discuss the latest tools for preventing and treating chest malignancies, which kill more than 1.3 million people each year.

At a press conference on Friday, 30 March 2007, at the Geneva Palexpo, reporters had the chance to hear senior scientists, clinicians and representatives of the World Health Organization (WHO) brief them on the latest approaches to targeted therapies, chemotherapy and, most crucially, the prevention of lung cancer. The press conference marked the opening of the European Society for Medical Oncology's International Symposium (EIS) on Chest Tumors.

"Over the next 25 years, the number of lung cancer deaths is projected to nearly double - to 2.2 million in 2030," according to WHO projections.

"The most effective way to fight lung cancer is to prevent it," said Dr. Catherine Le Galés-Camus, Assistant Director-General, Noncommunicable Diseases and Mental Health at the World Health Organization. "Effective prevention means combating the global epidemic of tobacco use and the other known environmental factors causing lung cancer, whether that is reducing exposure to coal-burning indoors or to ozone outdoors."

While in Geneva hosting the EIS on Chest Tumors, ESMO senior executives will meet with WHO officials to discuss ways of collaborating and strengthening clinicians' involvement to improve prevention and treatment for lung cancer.

"Cancer prevention spans a wide range of disciplines," said ESMO president, Håkan Mellstedt. These include population, nutrition, behavioral, environmental and social sciences; diagnostics; and clinical therapeutics like chemoprevention. "All of these help to identify and quantify cancer risk in individuals and family, ethnic, and racial groups. This is the main reason why cancer can truly be fought on all fronts and by all those who are touched in some way by this disease!"

"The ESMO International Symposium on Chest Tumors is a three-day meeting held in Geneva at which many of the world's leading cancer experts will gather," said Prof. Rafael Rosell, Hospital Germans Trias i Pujol Medical Oncology Service, a member of EIS on Chest Tumors Task Force.

Highlights will include:

* How genetic testing can improve the outcome of new targeted therapies for lung cancer (William Gullick, GB, Rolf Stahel, CH, and Giuseppe Giaccone, US)

* The major impact on survival time that will come from a new system for assessing the severity of patients' cancer (Peter Goldstraw, GB, Didier Lardinois, CH)

* New data on combing chemotherapy and radiotherapy from a large clinical trial (Cecile Le Pechoux, FR)

* The latest therapeutic approaches for advanced cancer, including using monoclonal antibodies (Cesare Gridelli, IT, Paris Kosmidis, GR, Robert Pirker, AT and Nick Thatcher, GB)

* A comprehensive report on novel approaches to mesothelioma, including new drugs like pemetrexed, vorinostat and bevacizumab (Paul Baas, NL).



About the European Society for Medical Oncology (ESMO)

The European Society for Medical Oncology (ESMO) is the leading European non-profit, professional organization for medical oncology with a focus on promoting multidisciplinary cancer treatment around the world.

ESMO unites medical oncologists, oncology specialists, healthcare professionals, caregivers, patients, policy-makers, the media and other key stakeholders in a global alliance committed to eradicating cancer and ensuring equal access to high quality treatment for all patients. Thanks to its state-of-the-art education and training programs, ESMO plays an instrumental role in providing the oncology community with the most up-to-date scientific research and information available. Through its flagship journal, Annals of Oncology, ESMO publishes articles on all aspects of clinical oncology. ESMO is dedicated to educating and supporting oncologists, optimizing patient care as well as equal access to it, disseminating cancer-specific information to the public, and advocating patient rights. As an authoritative voice in the fight against cancer, ESMO provides both the platform and the consultative expertise to influence national and international organizations as well as European authorities, in order to establish common standards for a multidisciplinary approach to cancer treatment.

To find out more about please visit http://www.esmo.org/

For further information or inquiries please contact the ESMO Communication Department

Gracemarie Bricalli

ESMO Communication Director



Vanessa Pavinato

European Society for Medical Oncology

Link to comment
Share on other sites

Join the conversation

You can post now and register later. If you have an account, sign in now to post with your account.

Reply to this topic...

×   Pasted as rich text.   Restore formatting

  Only 75 emoji are allowed.

×   Your link has been automatically embedded.   Display as a link instead

×   Your previous content has been restored.   Clear editor

×   You cannot paste images directly. Upload or insert images from URL.

  • Create New...

Important Information

By using this site, you agree to our Terms of Use.